睿智医药
Search documents
医药医疗股持续走强,创新药方向领涨,常山药业触及20cm涨停,股价再创历史新高,睿智医药、海辰药业、罗欣药业、昂利康、众生药业、联化科技等多股封板。
news flash· 2025-06-09 02:15
医药医疗股持续走强,创新药方向领涨,常山药业触及20cm涨停,股价再创历史新高,睿智医药、海 辰药业、罗欣药业、昂利康、众生药业、联化科技等多股封板。 ...
A股创新药板块持续走强,盘中掀起涨停潮,睿智医药、众生药业、罗欣药业、联化科技等多股封板涨停,常山药业、泰恩康涨超10%,一品红、悦康药业、圣诺生物等跟涨。
news flash· 2025-06-09 01:55
A股创新药板块持续走强,盘中掀起涨停潮,睿智医药、众生药业、罗欣药业、联化科技等多股封板涨 停,常山药业、泰恩康涨超10%,一品红、悦康药业、圣诺生物等跟涨。 ...
创新药概念持续走强 众生药业、罗欣药业等多股涨停
news flash· 2025-06-09 01:50
暗盘资金一眼洞悉庄家意图>> 创新药概念持续走强,睿智医药(300149)、众生药业(002317)、罗欣药业(002793)、联化科技 (002250)等多股涨停,常山药业(300255)、泰恩康(301263)涨超10%,一品红(300723)、悦康 药业、圣诺生物等跟涨。 ...
A股CRO概念板块震荡走强,睿智医药涨超17%,联化科技封板涨停,美诺华涨超9%,金凯生科、圣诺生物、万邦医药、皓元医药等跟涨。
news flash· 2025-06-09 01:46
A股CRO概念板块震荡走强,睿智医药涨超17%,联化科技封板涨停,美诺华涨超9%,金凯生科、圣诺 生物、万邦医药、皓元医药等跟涨。 订阅A股市场资讯 +订阅 ...
CRO概念板块走高 联化科技涨停
news flash· 2025-06-09 01:40
Group 1 - The CRO concept sector has seen a significant rise, with companies like Lianhua Technology (002250) hitting the daily limit up, indicating strong investor interest [1] - Ruizhi Pharmaceutical (300149) has increased by over 10%, reflecting positive market sentiment towards the CRO sector [1] - Other companies such as Meinuohua (603538), Jinkai Biotechnology (301509), Shengnuo Biotech, Wanbang Pharmaceutical (301520), and Haoyuan Pharmaceutical have also experienced gains, showcasing a broader trend in the industry [1]
睿智医药收盘下跌3.05%,最新市净率4.15,总市值50.59亿元
Sou Hu Cai Jing· 2025-06-05 09:11
Core Viewpoint - The company, Ruizhi Pharmaceutical, is experiencing a decline in stock price and net capital outflow, despite showing positive revenue and profit growth in its latest quarterly report [1][2]. Company Summary - Ruizhi Pharmaceutical's stock closed at 10.16 yuan on June 5, down 3.05%, with a latest price-to-book ratio of 4.15 and a total market capitalization of 5.059 billion yuan [1]. - The company reported a net capital outflow of 83.8388 million yuan on June 5, with a total outflow of 156.9818 million yuan over the past five days [1]. - The main business of Ruizhi Pharmaceutical includes providing drug discovery, development, and production services to global pharmaceutical companies, biotechnology firms, and research institutions [1]. - The company's primary products consist of chemical business, pharmacodynamics and pharmacokinetics, and macromolecule business [1]. - In the first quarter of 2025, the company achieved a revenue of 261 million yuan, representing a year-on-year increase of 11.37%, and a net profit of 6.6421 million yuan, reflecting a year-on-year growth of 126.09%, with a sales gross margin of 27.44% [1]. Industry Summary - The average price-to-earnings (PE) ratio for the industry is 40.82 (TTM) and 46.97 (static), with an average price-to-book ratio of 3.46 [2]. - The median PE ratio for the industry is 45.93 (TTM) and 53.09 (static), with a median price-to-book ratio of 2.73 [2].
95只A股筹码大换手(6月5日)





Zheng Quan Shi Bao Wang· 2025-06-05 09:05
| 002366 | 融发核电 | 6.86 | 29.26 | -2.56 | | --- | --- | --- | --- | --- | | 001332 | 锡装股份 | 37.08 | 29.26 | -10.00 | | 300703 | 创源股份 | 23.83 | 28.23 | -2.58 | | 603123 | 翠微股份 | 14.18 | 28.22 | 10.01 | | 831175 | 派诺科技 | 25.28 | 27.99 | 11.56 | | 871263 | 莱赛激光 | 22.46 | 27.99 | 3.50 | | 002342 | 巨力索具 | 6.29 | 27.90 | -1.26 | | 002537 | 海联金汇 | 8.70 | 27.56 | 2.47 | | 002115 | 三维通信 | 8.57 | 27.26 | 10.01 | | 301306 | 西测测试 | 44.92 | 26.75 | 20.01 | | 300163 | 先锋新材 | 3.91 | 26.59 | -7.13 | | 300945 | 曼卡龙 | 25.05 | ...
千万别踩雷!多只高位股股东拟减持(附股)
Feng Huang Wang Cai Jing· 2025-06-04 10:54
Market Overview - The three major stock indices collectively rose today, with nearly 4,000 stocks increasing in value. Key sectors showing strong performance include brokerage firms and diversified financials, as well as consumer goods and innovative pharmaceuticals [1] - The trading volume in the Shanghai and Shenzhen markets reached 1.15 trillion, indicating no significant increase in trading activity [1] Sector Performance - The beer and soft drink sectors performed well, driven by seasonal demand due to high summer temperatures. Stocks such as 嘉美包装 (Jia Mei Packaging), 乐惠国际 (Le Hui International), and 永顺泰 (Yong Shun Tai) hit their daily limit [1] - Recent trends show a concentration of capital in specific sectors, with significant interest in metals, non-metals, and mining due to rising global risk aversion and domestic resource policies. Key stocks include 紫金矿业 (Zijin Mining) and 赤峰黄金 (Chifeng Jilong Gold Mining) [5] - The electric equipment sector, particularly in renewable energy and nuclear power, is benefiting from technological breakthroughs and policy support. Notable stocks include 宁德时代 (CATL) and 中超控股 (Zhongchao Holdings) [5] Investment Trends - There is a noticeable trend of large funds "hugging" certain stocks, leading to repeated speculation on a few hot topics. This has resulted in significant short-term profit opportunities, although the sustainability of this trend is questionable [6] - High-profile stocks have seen substantial price increases without strong fundamental support, indicating that the market is driven by speculative trading rather than underlying business improvements [5][6] - Recent data shows that some high-performing stocks have experienced insider selling, with executives from 凯因科技 (Kain Technology) and 均瑶健康 (Jun Yao Health) reducing their holdings significantly [7][8]
“苏超”概念火遍全场 创新药板块持续活跃
Mei Ri Shang Bao· 2025-06-03 23:11
"南哥"刷屏 "苏超"概念爆火 "没有假球,全是世仇"、"比赛第一,友谊第十四"……这个假期,江苏城市足球比赛——"苏超"火爆程 度直逼欧冠。在比赛进入到白热化阶段之时,"南哥之争"火爆全网。 受其影响,整个端午假期,江苏流量呈爆发式增长。抖音话题"江苏城市联赛"播放量破亿次,素人短视 频占比超70%,虎扑"江苏联"频道单日访问量破百万。"苏超"门票销售也异常火爆,10元门票炒至500 元,揭幕战(镇江VS扬州)吸引1.8万名观众,盐城主场峰值达1.5万人。赛事期间,南京、苏州、无 锡、常州四大赛区周边酒店预订量同比增长210%,夜市经济带动效应显著。 正因如此,昨日上午,江苏板块表现非常强劲,整个板块一度有11只股票涨停。体育板块更是不遑多 让,金陵体育(300651)20%涨停,创源股份(300703)、康力源(301287)等个股表现非常强劲。 据同花顺(300033)数据,截至昨日下午收盘,江苏板块整体收涨0.87%,成分股中,莱赛激光30%涨 停,金陵体育20%涨停,康力源涨超12%,千红制药(002550)、锦鸿集团、永悦科技(603879)、龙 蟠科技(603906)、中衡设计(603017)、 ...
6.3复盘:大机会来了!
Sou Hu Cai Jing· 2025-06-03 15:32
Market Overview - The overall market sentiment is positive, with a strong start in June, indicating a potential for good performance this month [1] - The market is characterized by a combination of quantitative-driven rotation and retail investor-led clustering strategies [1] Index Performance - The three major indices opened lower but showed signs of recovery, with a trading volume of 1.14 trillion, remaining stable compared to the previous trading day [3] - The expectation for the first half of the week is a gradual upward movement in indices, while the latter half may see divergence and corrections [3] Market Sentiment - There were 67 stocks hitting the daily limit up and 6 hitting the limit down, with 3,190 stocks rising and 1,724 falling [4] - The sentiment is expected to continue improving, with opportunities for rotation among thematic stocks [4] Sector Opportunities - The pharmaceutical sector is performing strongly, with notable stocks like Shuyitai and Huason Pharmaceutical showing significant gains [6] - The nuclear power sector is also expected to see a rebound, with strong buying activity noted in the afternoon [7] - The stablecoin sector faced challenges, but there is potential for recovery in the coming days [8] - The consumer sector, particularly in pet-related businesses, is showing strong recovery, indicating ongoing opportunities for selective investments [8] Investment Strategy - The current market favors a focus on core stocks within specific sectors, with an emphasis on maintaining a cautious approach due to lower margin for error [8]